Structure of Recombinant Human SLCO1B1/LST-1/OATP-2
Recombinant Human SLCO1B1/LST-1/OATP-2 is a protein that belongs to the solute carrier organic anion transporter family. It is also known as liver-specific organic anion transporter 1 (LST-1) or organic anion-transporting polypeptide 2 (OATP-2). This protein is encoded by the SLCO1B1 gene and is primarily expressed in the liver.
The structure of Recombinant Human SLCO1B1/LST-1/OATP-2 consists of 12 transmembrane domains and a large extracellular loop. It also contains a glycosylation site in the extracellular loop, which is important for its proper functioning. The protein has a molecular weight of approximately 80 kDa and is highly conserved among different species.
Activity of Recombinant Human SLCO1B1/LST-1/OATP-2
Recombinant Human SLCO1B1/LST-1/OATP-2 is a membrane-bound protein that plays a crucial role in the transport of various endogenous and exogenous compounds across the cell membrane. It acts as a carrier protein, facilitating the uptake of a wide range of substrates, including bile acids, hormones, and drugs.
The activity of this protein is mainly dependent on its ability to bind to and transport substrates. It has a high affinity for organic anions and can also transport cations, making it a bidirectional transporter. The transport of substrates by Recombinant Human SLCO1B1/LST-1/OATP-2 is driven by the transmembrane electrochemical gradient, making it an active transporter.
Application of Recombinant Human SLCO1B1/LST-1/OATP-2
The activity of Recombinant Human SLCO1B1/LST-1/OATP-2 has important implications in various physiological processes and has been linked to several diseases. Its role in the transport of bile acids is essential for maintaining bile acid homeostasis, and any dysfunction in this process can lead to liver diseases, such as cholestasis.
The protein also plays a crucial role in the absorption, distribution, and elimination of drugs in the body. Its expression in the liver allows it to regulate the levels of drugs in the blood, making it an important factor in drug efficacy and toxicity. Variations in the SLCO1B1 gene have been associated with altered drug response and increased risk of adverse drug reactions.
In addition to its physiological roles, Recombinant Human SLCO1B1/LST-1/OATP-2 has also been extensively studied for its potential therapeutic applications. Due to its ability to transport a wide range of substrates, it has been explored as a drug delivery target for various diseases, such as cancer, viral infections, and metabolic disorders.
Furthermore, Recombinant Human SLCO1B1/LST-1/OATP-2 has been used in research studies to investigate the transport mechanisms of different compounds and to develop new drug therapies. The recombinant protein has also been used in drug screening assays to identify potential substrates and inhibitors for this transporter.
Conclusion
In summary, Recombinant Human SLCO1B1/LST-1/OATP-2 is a membrane-bound protein with 12 transmembrane domains and a large extracellular loop. It plays a crucial role in the transport of various endogenous and exogenous compounds, including bile acids, hormones, and drugs. Its activity is essential for maintaining normal physiological functions and has important implications in disease states. The recombinant protein has also been widely used in research and drug development, making it a valuable tool in the scientific community.
There are no reviews yet.